Sign In

Julie Grant

Julie Grant is the Co-Founder and Chief Executive Officer at Day One Biopharmaceuticals. Unfortunately, I don't have access to detailed information about her professional background or achievements from the provided search results. The LinkedIn profile you mentioned could not be accessed, so I cannot provide specific details about her career history or educational background. If you need more information about Julie Grant, you may want to search for other reliable sources or official company information from Day One Biopharmaceuticals.

Highlights

Apr 17 · linkedin

Two big announcements at Canaan today: a new Partner and additional capital dedicated to biopharmaceuticals.

Uwe Schoenbeck, Head of External R&D at Pfizer, has joined our investment team as Venture Partner. Uwe's data driven approach to decisions, proven ability to enable others to succeed, love of novel science, and quick ability to come to an informed point of view stood out to us. He is brilliant, kind, direct, and understated about his long list of accomplishments. We laugh together as a team. These are exactly the characteristics we seek when partnering with entrepreneurs and scientific founders to build important medicines and companies. Welcome Uwe! He is in NY. Send him a note when you are in town.

Also, we announced the expansion of capital dedicated to therapeutic medicines, bringing the total capital to invest over the next 3 years to over $1B. The additional capital was raised with the tremendous support from our LPs as a result of returns generated by outstanding biopharma start-ups. The capital allows us to continue to expand our team and invest in ~15 companies over the next few years. We look forward to unveiling new company formation efforts, syndicated series As, and a few select investments in series B+ private biopharma companies. This sector specific fund will invest in parallel with our main diversified fund.

Thank you to my incredible teammates at Canaan, our LPs who entrust their capital with us, and the entrepreneurs who magically convert science into medicines. It is a honor to continue to build Canaan together and make a positive impact upon the world.

May 25 · linkedin

Live from Eisenhower Executive Office Building in DC. ‘We are here today because we have important work to do,’ are the opening words from Dr. Arati Prabhakar, Director of the White House Office of Science & Technology Policy and Assistant to the President for Science and Technology. Listen live to the open sessions from the link below.

Excited to learn and contribute during today’s focus on #GBM and #DIPG, two of the worst brain cancers. Leaders come together to talk about solutions thanks to the leadership of Dr. Danielle Carnival, PhD, Deputy Assistant to the President for the #cancermoonshot and Deputy Director of Health Outcomes, White House Office of Science and Technology Policy.

I am confident than innovation and execution from nimble small biotechs can make a difference for patients and families waiting. It will take collaboration and creative work across government, scientists, families, physicians and the broader community. We see medicines that create hope and miracles across so many cancers. We see cures and durable remissions. How can we make brain cancers the next to benefit?

The first step is to believe that we will cure these diseases.

https://lnkd.in/gS-Qm9Qp

#cancer #braincancer #biotech Canaan

Related Questions

What is Julie Grant's background before co-founding Day One Biopharmaceuticals?
What are some key achievements of Julie Grant at Day One Biopharmaceuticals?
How did Julie Grant and her co-founders come up with the idea for Day One Biopharmaceuticals?
What are the main goals and objectives of Day One Biopharmaceuticals under Julie Grant's leadership?
What industries or sectors has Julie Grant worked in before joining Day One Biopharmaceuticals?
Julie Grant
Add to my network

Location

San Francisco Bay Area